HEMANOVA specializes in the R&D and manufacturing of in vitro diagnostic reagents, covering clinical chemistry, immunoassay, molecular, coagulation and QC platforms, delivering stable and traceable testing solutions for laboratories worldwide.
Founded
Registered products & pipeline projects
Partner institutions & laboratories
National service network coverage
From routine chemistry to molecular diagnostics, from reagents to QC and calibration, HEMANOVA responds to diverse laboratory needs with a complete product portfolio and supporting services.
Routine and specialty assays covering liver, renal and lipid panels and glucose metabolism, compatible with mainstream automated chemistry analyzers.
Explore the rangeMagnetic particle chemiluminescence platform focused on infection, cardiac, tumor and metabolic markers with high-sensitivity detection for clinicians.
Explore the rangeFluorescent PCR and multiplex technologies covering pathogen nucleic acids, viral load and genotyping applications.
Explore the rangeClotting and immunoturbidimetric reagents with matching QC and calibration systems, supporting routine coagulation and anticoagulation monitoring.
Explore the rangeHuman serum matrix controls and multi-analyte calibrators for internal QC, external assessment and result traceability.
Explore the rangeReaction cups, diluents and wash solutions ensuring stable, continuous operation of testing systems.
Explore the rangeFocused on infection, cardiovascular, respiratory and thrombosis testing, delivering stable, traceable reagents clinicians can rely on.
Supports diagnosis and monitoring of bacterial infection and sepsis, covering low- and high-value samples.
High-sensitivity detection supporting early recognition, diagnosis and risk stratification of acute myocardial infarction.
Multiple common respiratory pathogens in one tube, with built-in internal control and contamination prevention.
Supports assessment of thrombosis and hyperfibrinolysis; fits mainstream automated coagulation analyzers.
Founded in 2012, HEMANOVA Biotech (Shanghai) Co., Ltd. is headquartered in Zhangjiang, Shanghai, with an R&D and manufacturing base in Suzhou. We focus on the development, production and technical service of in vitro diagnostic reagents, making high-quality test results more accessible.
We have built five technology platforms — clinical chemistry, chemiluminescence, molecular PCR, coagulation and QC calibration. Our products serve 28 provincial-level regions across China and markets in Southeast Asia, the Middle East and Europe. From raw material selection to product release, systematic quality management ensures the consistency of every batch.
We organize R&D, production and service under the ISO 13485 medical device quality management system. Formulation, filling and packaging take place in ISO Class 8 cleanrooms, and incoming material inspection, process control, finished product release and retained-sample stability studies together build quality assurance across the product life cycle.
End-to-end control across design, purchasing, production, release and post-market surveillance.
Automated formulation and filling lines with real-time recording and trend analysis of critical parameters.
Raw material lots, production records and test data are linked, so issues can be quickly located and closed out.
Dual sourcing and safety stock for key raw materials, with cold-chain logistics for reliable delivery.
Our application team reviews your assay menu, sample volume and platform requirements, then recommends a product mix and validation plan.
We support method validation, reference interval confirmation and staff training to establish standardized workflows.
Lot management and cold-chain logistics secure delivery, with appropriate safety stock for key products.
QC data reviews, technical follow-ups and rapid response mechanisms continuously support laboratory quality improvement.
Follow HEMANOVA's product progress, quality practices and industry activities.
The CL series platform for mid- to large-sized laboratories has been upgraded with further improvements in throughput, reagent loading and end-to-end traceability.
The audit covered design, purchasing, production, quality control and post-market surveillance; the auditors affirmed our system performance.
Presenting four product lines — chemistry, immunoassay, molecular and coagulation plus QC — and exchanging views on standardized testing with laboratories.